Do You Think You Have High Alcohol Tolerance? Here’s How Liquor Impacts Your Brain Activity

Updated Aug 9, 2024 | 03:00 PM IST

SummaryA recent research sheds light on social drinkers and how even moderate alcohol consumption can impact brain activity, challenging the notion that occasional drinking is harmless.
Liquor Impacting Brain Activity (Credit-Freepik)

Liquor Impacting Brain Activity (Credit-Freepik)

Many of us believe that we are great drinkers and that alcohol does not affect us as much. People who are able to drink without showing any sign of inebriation are known as social drinkers. In short, they are not addicted to alcohol but will not turn down the opportunity to have a good time! While it may seem like it doesn’t affect you, new studies suggest that it is just an illusion, even if you have high tolerance, alcohol affects your cognitive and motor functions more than you think.

The study reveals the below implications and techniques:

  • Researchers used a new MRI technique to precisely measure brain electrical activity.
  • By comparing brain scans before and after drinking, scientists identified specific areas affected by alcohol and how much brain activity slowed down.
  • Participants were chosen to be regular social drinkers without alcohol addiction, ensuring the study focused on the effects of alcohol alone.
  • MRI technology provided reliable data on brain activity changes caused by alcohol consumption.

How does the brain react to alcohol?

The human brain is a complex network of billions of neurons that communicate through electrical impulses. Brain conductivity refers to the efficiency with which these electrical signals travel through brain tissue. It's akin to the speed and clarity of a digital signal through a wire. In layman terms, your brain must function in its peak condition as it is essential for various cognitive processes, including memory, attention, decision-making, and motor control.

Think of it as the foundation for your brain's performance. When brain conductivity is high, information flows smoothly, and that helps your brain in rapid processing and response. On the other hand, low conductivity can hinder cognitive function, leading to slower thinking, impaired memory, and difficulties with coordination.

A study conducted at the Neuroscience Research Australia (NeuRA) and UNSW Science unveiled a startling connection between alcohol consumption and brain conductivity.

What is the connection between alcohol consumption and brain activity?

While many people brush off the effects of alcohol as temporary changes in behaviour, the reality is much more complex. Beyond the obvious impacts on coordination and judgment, alcohol significantly alters brain function. Alcohol dramatically slowed down brain activity, especially in areas responsible for decision-making, planning, and physical coordination. This decline was so significant that it resembled the brain changes seen in normal ageing. This means even one drink could temporarily accelerate the ageing process of your brain.

Alcohol and Brain activity: What does the study Imply?

The implications of this research are far-reaching. It provides compelling evidence that alcohol consumption has a direct and measurable impact on brain function. The discovery that alcohol can significantly reduce brain conductivity opens new avenues for understanding the neurocognitive effects of alcohol abuse and dependence. While you may not feel like alcohol is affecting you and you have a high tolerance, it most definitely changes and affects your decision-making abilities and impulse control.

Furthermore, the MRI technique employed in the study could be a valuable tool for assessing the impact of other substances on the brain and for developing interventions to mitigate alcohol-related brain damage.

End of Article

Catherine O'Hara Cause Of Death Is Pulmonary Embolism; She Also Had Rectal Cancer

Updated Feb 10, 2026 | 10:19 AM IST

SummaryCatherine O’Hara died aged 71 from pulmonary embolism, with rectal cancer listed as a long-term condition. Pulmonary embolism is a life-threatening blood clot often linked to deep vein thrombosis, and cancer increases clot risk. O’Hara also had situs inversus.
Catherine O’Hara’s cause of death is pulmonary embolism

Credits: Wikimedia Commons

Catherine O'Hara's cause of death is pulmonary embolism, confirmed medical examiner. She died on January 30 in a Los Angeles hospital, at the age of 71. The Schitt's Creek star also had blood clot in her lungs and her death certificate also listed rectal cancer as the long term cause of death.

She had been receiving treatment for the cancer since March 2025.

Catherine O'Hara Cause Of Death: What Is Pulmonary Embolism?

As per the National Health Service (NHS), a pulmonary embolism is a life-threatening condition that happens when a blood vessel in the lungs is blocked by a blood clot.

The common symptoms may include:

  • Difficulty in breathing
  • Chest pain
  • Cough up blood

The blood clot starts in a deep vein in the leg and travels to the lung in most cases. Rarely, the clot forms in a vein in another part of the body, noted Mayo Clinic. When a blood clot forms in one or more of the deep veins in the body, it is called a deep vein thrombosis or DVT.

Other symptoms of pulmonary embolism include:

  • irregular heartbeat
  • lightheadedness or dizziness
  • excessive sweating
  • fever
  • leg pain or swelling, usually at the back of lower leg
  • clammy or discolored skin

As per Cleveland Clinic, about a third of people with a pulmonary embolism die before diagnosis and treatment, highlighting the condition's severity.

Catherine O'Hara Cause Of Death: She Also Had Rectal Cancer

Catherine O'Hara also was battling rectal cancer, which had been a long-term health challenge for her. The diagnosis was kept private. As per TMZ and The Associated Press, the diagnosis was kept private with only close family and her medical team aware of the details. Her struggle with cancer was not widely known, which made her news of rectal cancer more shocking to her fans and many in the industry.

Rectal cancer is a serious and often aggressive disease. According to the Mayo Clinic and the American Cancer Society, it typically starts as abnormal growths known as polyps in the rectum and can require intensive treatment, including surgery, radiation, and chemotherapy. Colorectal cancer—which includes cancers of both the colon and rectum—remains one of the leading causes of cancer-related deaths in the United States. This year, nearly 50,000 people are expected to be diagnosed with rectal cancer, while colorectal cancer overall is projected to claim around 55,000 lives nationwide.

Rectal cancer too can increase the risk of developing blood clots, making complications like pulmonary embolism, more common among cancer patients.

Catherine O'Hara Cause Of Death: She Was Born With A Rare Genetic Condition

Speaking in previous interviews, O'Hara revealed that she was born with a rare genetic condition called situs inversus. This means the organs are mirrored from their usual positions. Her heart, for instances, pointed to the right side of her chest, a condition known as dextrocardia. While this is a harmless condition, situs inversus could sometimes be associated with other complications.

End of Article

ER Patients in Massachusetts Wait 3+ Hours on Average, Third-Longest in the US

Updated Feb 10, 2026 | 09:55 AM IST

SummaryER Patients in Massachusetts Wait: Massachusetts has the third-longest emergency room wait times in the US, with patients waiting over three hours on average, according to national data. Long delays highlight hospital shortages, ER boarding and growing pressure on the healthcare system.
ER Patients in Massachusetts Wait Over Three Hours on Average, Third-Longest in the US

Credits: Canva

ER Patients in Massachusetts Wait: Any visit to hospital must be treat with uttermost urgency, especially when it is the visit to the ER. What is worse is waiting a long time to see a doctor or a medical team even during an ER visit. A new analysis by health insurance experts at Compare the Market finds that the US has the lowest number of hospitals, per capita, in the world, which means 1.84 hospitals per 100,000 citizens. This is what makes the waiting time longer.

This has placed US behind countries like Chile which has 1.85 hospitals per 100,000 citizens and Thailand with 1.89 hospitals per 100,000 citizens. According to the same analysis, South Korea ranks top with 7.38 hospitals per 100,000 citizens, followed with Japan with 6.64 hospitals per 100,000 citizens. Among the 54 countries evaluated in the analysis, the United States ranked 29.

ER Patients in Massachusetts: Longest Wait Hours In US

US StatesER Wait Time (in minutes)
Maryland228
Delaware195
Massachusetts189
Rhode Island185
New York184
Arizona176
New Jersey173
Connecticut166
California164
Illinois157
While the study compares hospitals across global population, an analysis by the World Population Review studied the ER wait time within US hospitals and found that Massachusetts ranked 3rd in the nation for long wait list. The review showed that it takes over 3 hours or 189 minutes to get your chance during an ER visit.

ER Patients in Massachusetts Wait Over Three Hours on Average, Third-Longest in the US

The top on the list was Maryland with 228 minutes, or almost 4 hours, followed by Delaware with 195 minutes.

ER Patients in Massachusetts: Long Wait Hours Leads To Death

There have been cases where long ER waits have led to patients' deaths in the US. A KKTV report from 2022 notes a 77-year-old North Carolina patient who went to New Hanover Regional Medical Center waited for more than 5 hours. The patient met with a triage at 8.43pm and was given an urgent designation, but was told to sit in the waiting room. Investigation revealed that she was not assessed until the next day at 8.am for her vitals to be taken. The woman was pronounced dead at 4.25am.

A Fortune report from 2025 interviewed an Illinois family who lost their father Bill Speer to ER boarding. Tracy Balhan, the daughter revealed that her father died after struggling with dementia. She took him to the emergency room at Endeavor Health's Edward Hospital in Chicago suburb of Naperville. However, Speer spent 12 hours in the ER.

An older report by EMS World from 2011, revealed a case of a Texas man who died after waiting for 16 hours for treatment in ER.

This is not just the case in the US, but a very recent case reported by Health and Me was of a 44-year-old Indian origin man, Prashant Sreekumar, who died at a Canadian hospital's ER after an 8-hour weight. His father, Kumar Sreekumar told the Global News that he was checked in at triage and then seated in the waiting room. When his father reached the hospital, he told him, "Papa, I cannot bear the pain." "It went up, up, and up. To me, it was through the roof," his father said. He was finally called for treatment after more than eight hours of wait." After sitting maybe 10 seconds, he looked at me, he got up and put his hand on his chest and just crashed," his father said.

ER Patients in Massachusetts: What Is ER Boarding?

Read: “Papa, I Can’t Bear the Pain”, Says Indian-Origin Man Who Dies After Eight-Hour ER Wait in Canada

ER boarding is a common term that is used to highlight the health care system's struggle which includes shrinking points of entry for patients seeking care outside of ERs and hospitals prioritizing beds for procedures insurance companies often pay more for, and for making patients wait long hours for ER visits.

1 in 6 visits to the ER in 2022 that resulted in hospital admission had a wait of four or more hours, as per an Associated Press and Side Effects Public Media data analysis.

End of Article

Wegovy Pill: FDA Says The TV Ad By Novo Nordisk On Its Weight Loss Pills Are Misleading

Updated Feb 10, 2026 | 06:39 AM IST

SummaryFDA has flagged Novo Nordisk’s Wegovy obesity pill advertisement for making false and misleading claims, saying it exaggerates superiority, emotional benefits and downplays risks. The regulator warned the ad misbrands the drug, urged immediate corrective action, as competition and legal pressure intensify.
Wegovy Pill: FDA Says The TV Ad By Novo Nordisk On Its Weight Loss Pills Are Misleading

Credits: Canva

Wegovy pill by Novo Nordisk is now under scrutiny after the US Food and Drug Administration (FDA) raised concerns over a television advertisement. FDA said that the commercial includes "false and misleading" claims about the obesity drug's benefits.

In a letter (reported first by Bloomberg) dated February 5, the FDA said the advertisement misbrands the oral weight loss drug. FDA said that it made its distribution a potential violation of federal law. FDA has asked the Danish drugmaker to take immediate corrective action, which include:

  • Pulling the ad
  • Revising all advertisements that contain misleading statements

Wegovy Pill: FDA Questions Claims of Superiority and Emotional Benefits

As per the letter, the FDA found that the ad misleadingly suggests the Wegovy pill offers superior benefits when compared to other approved GLP-1 weight loss drugs. The regulator flagged phrases such as “live lighter” and “a way forward,” saying they imply greater weight loss and added advantages without evidence to support those claims.

The FDA also took issue with what it describes as emotional and psychological messaging, saying that the ad appears to imply benefits beyond physical weight loss, including emotional relief, reduced psychological burden, hope, or direction in life. FDA notes that this claim positions the drug as a solution to broader life challenges rather than just a treatment to obesity.

Furthermore, FDA said that the ad failed to adequately present risk information in both audio and text formats, which is mandatory requirement for television drug advertising.

Wegovy Pill: Novo Nordisk Responds To FDA Notice

Novo Nordisk confirmed on Monday that it has received the FDA’s letter. The company clarified that while the advertisement has been running since the pill’s launch, it is not linked to its Super Bowl advertising.

“We take all regulatory feedback seriously and are in the process of responding to the FDA to address their concerns regarding the advertisement’s presentation,” said Liz Skrbkova, Novo Nordisk’s head of US media and stakeholder relations, in a statement.

Novo Nordisk is already under pressure to defend its position in the weight loss market, as it is facing a stiff competition from rival Eli Lilly. Furthermore, on Monday, Novo also filed a lawsuit against telehealth company Hims & Hers, seeking to block the mass marketing of compounded versions of its Wegovy pill and injections.

Read: Wegovy Pills Now Available At Your Pharmacies, Here's What To Know About Its Usage

Wegovy Pill: How Effective Is It?

After injection by Novo Nordisk, of the same name, Wegovy, which has been on the market since 2021, its popularity grew so much that it was in short supply until February 2025. The pill version has now come out, which many experts believe will expand its accessibility. As the monthly supply of pill is expected to be cheaper than the monthly supply of the weight loss injection.

A study published in the New England Journal of Medicine show that a 25 milligram Wegovy pill led to 13.6% reduction in weight on average over 64 weeks. When compared to placebo, the result was only 2.2% of weight loss. Novo Nordisk says that those who stayed on the treatment and reduced their calorie intake, it would lead to a loss of 16.6% of their weight.

Wegovy Pill: What Are The Side Effects?

Digestive problems such as nausea and vomiting remain the most common side effects of GLP-1 drugs. These issues were also reported in studies of the pill versions. Around 7 percent of participants taking the Wegovy pill stopped treatment because of side effects, compared with 6 percent in the placebo group. In orforglipron’s trial, up to 10 percent of patients discontinued treatment, compared with 3 percent on placebo.

One key difference lies in how the medications are used. The Wegovy pill must be taken on an empty stomach with a small amount of water. Patients are advised not to eat, drink, or take other medicines for at least 30 minutes afterward. Doctors say this requirement has limited the use of Rybelsus, the pill form of semaglutide approved for diabetes, compared with Ozempic.

End of Article